Label: RENAPLUS- potassium gluconate tablet
- NDC Code(s): 13985-060-45
- Packager: MWI/VetOne
- Category: PRESCRIPTION ANIMAL DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated December 29, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- INDICATION:
- CONTAINS:
- STORAGE:
- SPL UNCLASSIFIED SECTION
- DOSAGE:
- WARNING:
- PRECAUTION:
- SPL UNCLASSIFIED SECTION
- DISPLAY PANEL - RENAPLUS TABLETS 100 Tablet Bottle
-
INGREDIENTS AND APPEARANCE
RENAPLUS
potassium gluconate tabletProduct Information Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:13985-060 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength POTASSIUM GLUCONATE (UNII: 12H3K5QKN9) (POTASSIUM CATION - UNII:295O53K152) POTASSIUM GLUCONATE 468 mg Product Characteristics Color white Score no score Shape ROUND Size 11mm Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13985-060-45 100 in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 04/24/2013 Labeler - MWI/VetOne (019926120) Registrant - Neogen Corporation-Mercer (042125879) Establishment Name Address ID/FEI Business Operations Neogen Corporation-Mercer 042125879 analysis, manufacture, label Establishment Name Address ID/FEI Business Operations Jungbunzlauer Ladenburg GmbH 322121609 api manufacture